These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 8652289)
1. Oral chemotherapy with doxifluridine and folinic acid in biliary tract cancer. Colleoni M; Di Bartolomeo M; Di Leo A; Zilembo N; Carnaghi C; Pandolfi A; Rimassa L; Artale S; Bajetta E Eur J Cancer; 1995 Dec; 31A(13-14):2426-7. PubMed ID: 8652289 [No Abstract] [Full Text] [Related]
2. Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-FU) containing regimens. Bajetta E; Di Bartolomeo M; Somma L; Del Vecchio M; Artale S; Zunino F; Bignami P; Magnani E; Buzzoni R Eur J Cancer; 1997 Apr; 33(4):687-90. PubMed ID: 9274455 [TBL] [Abstract][Full Text] [Related]
3. Doxifluridine: an active agent in advanced gastrointestinal cancer. Di Bartolomeo M; Bajetta E; Somma L; Buzzoni R Tumori; 1995; 81(3 Suppl):147-50. PubMed ID: 7571047 [TBL] [Abstract][Full Text] [Related]
4. Relief of jaundice by 5-fluorouracil and folinic acid in patients with recurrent gastric cancer. Kajiyama Y; Tsurumaru M; Udagawa H; Tsutsumi K; Kinoshita Y; Akiyama H Surg Oncol; 1996 Aug; 5(4):177-81. PubMed ID: 9067566 [TBL] [Abstract][Full Text] [Related]
5. Chronomodulated 5-day infusion of floxuridine and L-folinic acid in patients with advanced malignancies: a feasibility and tolerability study. Garufi C; Lévi F; Giunta S; Aschelter A; Pace R; Nisticò C; Terzoli E J Infus Chemother; 1995; 5(3 Suppl 1):134-7. PubMed ID: 8528973 [TBL] [Abstract][Full Text] [Related]
6. Oral doxifluridine plus levoleucovorin in elderly patients with advanced breast cancer. Bajetta E; Biganzoli L; Carnaghi C; Di Bartolomeo M; Spagnoli I; Cassata A; Galante E; Mariani L; Stampino CG; Buzzoni R Cancer; 1998 Sep; 83(6):1136-41. PubMed ID: 9740078 [TBL] [Abstract][Full Text] [Related]
7. Common vitamin B complex agents and folic acid: Part IV. Leucovorin calcium (citrovorum factor, folinic acid [wellcovorin]). Claussen DW Gastroenterol Nurs; 1997; 20(3):107-8. PubMed ID: 9238940 [No Abstract] [Full Text] [Related]
8. Oral doxifluridine plus leucovorin in metastatic colorectal cancer: randomized phase II trial with intravenous 5-fluorouracil plus leucovorin. Ahn JH; Kim TW; Lee JH; Min YJ; Kim JG; Kim JC; Yu CS; Kim WK; Kang YK; Lee JS Am J Clin Oncol; 2003 Feb; 26(1):98-102. PubMed ID: 12576934 [TBL] [Abstract][Full Text] [Related]
9. A phase II study of doxifluridine in patients with advanced breast cancer. Alberto P; Jungi WF; Siegenthaler P; Mermillod B; Obrecht JP; Decoster G; Cavalli F Eur J Cancer Clin Oncol; 1988 Mar; 24(3):565-6. PubMed ID: 2968264 [No Abstract] [Full Text] [Related]
10. Randomized phase II noncomparative trial of oral and intravenous doxifluridine plus levo-leucovorin in untreated patients with advanced colorectal carcinoma. Bajetta E; Di Bartolomeo M; Somma L; Moreschi M; Comella G; Turci D; Gebbia V; Scanni A; Bordogna G; Stampino CG Cancer; 1996 Nov; 78(10):2087-93. PubMed ID: 8918401 [TBL] [Abstract][Full Text] [Related]
11. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin. Klaassen U; Wilke H; Seeber S J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323 [TBL] [Abstract][Full Text] [Related]
12. A phase I study of combined radiation therapy with 5-fluorouracil and low dose folinic acid in patients with locally advanced pancreatic or biliary carcinoma. Hsue V; Wong CS; Moore M; Erlichman C; Cummings BJ; MacLeod M Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):445-50. PubMed ID: 8567347 [TBL] [Abstract][Full Text] [Related]
13. Regional chemotherapy in biliary tract cancers--a single institution experience. Melichar B; Cerman J; Dvorák J; Jandík P; Mergancová J; Melicharová K; Tousková M; Krajina A; Voboril Z Hepatogastroenterology; 2002; 49(46):900-6. PubMed ID: 12143237 [TBL] [Abstract][Full Text] [Related]
14. Phase II clinical trial of doxifluridine in patients with advanced ovarian cancer. van Oosterom AT; ten Bokkel Huinink WW; van der Burg ME; Vermorken JB; Willemse PH; Neijt JP Eur J Cancer; 1991; 27(6):747-9. PubMed ID: 1829917 [TBL] [Abstract][Full Text] [Related]
15. Fluorouracil-based combinations in the treatment of metastatic breast cancer. Klaassen U; Wilke H; Harstrick A; Seeber S Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):31-5. PubMed ID: 9516601 [TBL] [Abstract][Full Text] [Related]
16. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma. Edelman MJ; Meyers FJ; Houston J; Lauder I Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of primary and secondary liver tumors using a combination of chemotherapy and surgery]. Pettavel J; Morgenthaler FR Schweiz Med Wochenschr; 1975 May; 105(18):596-8. PubMed ID: 124947 [TBL] [Abstract][Full Text] [Related]
18. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial. Ducreux M; Van Cutsem E; Van Laethem JL; Gress TM; Jeziorski K; Rougier P; Wagener T; Anak O; Baron B; Nordlinger B; Eur J Cancer; 2005 Feb; 41(3):398-403. PubMed ID: 15691639 [TBL] [Abstract][Full Text] [Related]